BDBM380201 N-[4-(4-oxo-3,4- dihydrophthalazin-1- yl)phenyl]-3-phenyl-4,5- dihydro-1,2-oxazole-5- carboxamide::US9926282, Example 196

SMILES O=C(Nc1ccc(cc1)-c1n[nH]c(=O)c2ccccc12)C1CC(=NO1)c1ccccc1

InChI Key InChIKey=FETMOFPWAUVBFP-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 380201   

TargetRho-associated protein kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM380201(N-[4-(4-oxo-3,4- dihydrophthalazin-1- yl)phenyl]-3...)
Affinity DataIC50: 550nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2020
Entry Details
Go to US Patent

TargetRho-associated protein kinase 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM380201(N-[4-(4-oxo-3,4- dihydrophthalazin-1- yl)phenyl]-3...)
Affinity DataIC50: 2.55E+4nMAssay Description:The effectiveness of compounds of the present invention as ROCK inhibitors can be determined in a 30 μL assay containing 20 mM HEPES, pH 7.5, 20...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/10/2020
Entry Details
Go to US Patent